Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bi Naotong Nasal Spray Local Tolerability Study
CTR20140387Phase 2Completed
- Sponsor
- Qifu Ruicao Medical Technology
- Start
- Jun 2014
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Binaotong in migraine, sponsored by Qifu Ruicao Medical Technology. Started Jun 2014; status: completed.
02
Drugs
Binaotong
03
Conditions
migraine
Beyond the preview
Go deeper on CTR20140387.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20140387.